Skip to main content

Find Clinical Trials

Home
Conditions
Postmenopausal Osteoporosis

Clinical trial condition

Postmenopausal Osteoporosis

Explore clinical trials studying Postmenopausal Osteoporosis. Study availability and eligibility vary by location and protocol.

95 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Postmenopausal Osteoporosis trial results

Completed

Efficacy and Safety Study on Menatetrenone in the Treatment of Postmenopausal Osteoporosis Women

NCT00165698

Conditions: Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +5 more
Locations: Beijing Hospital Beijing, China

Chinese PLA General Hospital Beijing, China

Peking Union Medical College Hospital Beijing, China

Hua Dong Hospital Shanghai, China

View Trial Details

Completed

A High-resolution Peripheral Quantitative Computed Tomography Study in Postmenopausal Women Previously Treated With Denosumab

NCT00890981

Conditions: Bone Diseases, Bone Diseases, Metabolic, Low Bone Mass, +7 more
Locations: Not specified

View Trial Details

Completed

A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab

NCT00887965

Conditions: Bone Diseases, Bone Diseases, Metabolic, Low Bone Mass, +7 more
Locations: Not specified

View Trial Details

Completed

Parathyroid Hormone (PTH) for Osteoporosis in Postmenopausal Women

NCT00086619

Conditions: Bone Diseases, Bone Diseases, Metabolic, Bone Resorption, +6 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Study of Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Alendronate or Risedronate

NCT00778154

Conditions: Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +5 more
Locations: Warner Chilcott Research Facility Palm Desert, California, United States

Warner Chilcott Research Facility Lakewood, Colorado, United States

Warner Chilcott Research Facility Decatur, Georgia, United States

Warner Chilcott Research Facility Gainesville, Georgia, United States

View Trial Details

Completed

A Study of Monthly Risedronate for Osteoporosis

NCT00247273

Conditions: Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +5 more
Locations: Research Site Lakewood, Colorado, United States

Research Site Gainesville, Georgia, United States

Research Site Bethesda, Maryland, United States

Research Site Omaha, Nebraska, United States

View all 49 locations

View Trial Details

Completed

A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis

NCT00541658

Conditions: Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +5 more
Locations: Research Site Birmingham, Alabama, United States

Research Site Oakland, California, United States

Research Site San Diego, California, United States

Research Facility Walnut Creek, California, United States

View all 45 locations

View Trial Details

Completed

Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of PTH Analog Tablets in Postmenopausal Women

NCT01321723

Conditions: Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +5 more
Locations: CCBR Aalborg, Denmark

CCBR Ballerup Municipality, Denmark

CCBR Vejle, Denmark

CCBR Tallinn, Estonia

View Trial Details

Completed

A Study to Evaluate the Safety and Efficacy of Denosumab and Ibandronate in Postmenopausal Women Sub-Optimally Treated With Daily or Weekly Bisphosphonates

NCT00936897

Conditions: Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin of Postmenopausal Women With Low Bone Mass

NCT01572545

Conditions: Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +6 more
Locations: 251 Hellenic Air Force Hospital Athens, Attikis, Greece

424 General Military Hospital Thessaloniki, Greece

Second Medical Clinic, Medical School, Aristotle University of Thessaloniki, Ippokration Hospital Thessaloniki, Greece

View Trial Details